Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
3SBio Inc. Announces Expansion of its Leadership Team 2016-03-04 19:03
3SBio Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Conjugate Targeting HER2 with Alteogen 2015-10-12 08:05
3SBio Inc. Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap Index 2015-08-17 22:46
3SBio Acquires Zhejiang Wansheng Pharmaceutical 2015-07-24 17:07
3SBio Acquires Global Rights to Anti-TNF mAb 2015-06-22 20:55
1 2